Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats

Hepatology

Volumn 55, Issue 5, 2012, Pages 1540-1550

  Yang, Ying Ying ^a,b   Tsai, Tung Hu ^b   Huang, Yi Tsau ^b,c   Lee, Tzung Yan ^d   Chan, Che Chang ^a,b   Lee, Kuei Chuan ^a,b   Lin, Han Chieh ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CYTOCHROME P450 2E1; ENDOCANNABINOID; ENDOTHELIN 1; GLUCOSE; HYDROXYPROLINE; LEPTIN; LEPTIN RECEPTOR; LIVER PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPONTIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROGENESIS; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; HISTOPATHOLOGY; HYPERLEPTINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KUPFFER CELL; LEUKOCYTE; LIVER CIRRHOSIS; LIVER PERFUSION; MICROCIRCULATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STELLATE CELL; VASOCONSTRICTION;

ANIMALS; BIOPSY, NEEDLE; BODY WEIGHT; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOCANNABINOIDS; ENDOTHELIN-1; FATTY LIVER; HEPATIC STELLATE CELLS; HYPERTENSION, PORTAL; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; KUPFFER CELLS; LEPTIN; LIVER; MICROCIRCULATION; RANDOM ALLOCATION; RATS; RATS, ZUCKER; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 84859980025     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25534     Document Type: Article

References (32)

1. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang T, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122: 288-297.
2. Heo YR, Claycombe K, Jones BH, Wright P, Truett GE, Zemel M, et al. Effects of fatty (fa) allele and high fat diet on adipose tissue leptin and lipid metabolism. Horm Metab Res 2002; 34: 686-690.
3. Serkova NJ, Jackman M, Brown JL, Liu T, Hirose R, Robert JP, et al. Metabolic profiling of livers and blood from obeses Zucker rats. J Hepatol 2006; 44: 956-962.
4. Rinella ME, Elias MS, Smolak RR, Borensztajn J, Green RM. Mechanism of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res 2008; 49: 1068-1076.
5. Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, Oo YH, et al. Osteopontin is induced by Hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. HEPATOLOGY 2011; 53: 106-115.
6. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 2005; 19: 136-138.
7. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrel GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. HEPATOLOGY 2004; 40: 386-393.
8. Francque S, Wamutu S, Chatterjee S, Van Marck E, Herman A, Ramon A, et al. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splachnic vasodilatation and signs of a hyperdyanmic circulation in vitro and in vivo in a rat model. Liver Int 2010; 30: 365-375.
9. Vollmar B, Siegmund S, Menger MD. An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing fibrosis in rats. Hepatology 1998; 27: 1544-1553.
10. Yokoyama Y, Wawrzyiak A, Baveja R, Sonin N, Clemens MG, Zhang JX. Altered endothelin receptor expression in prehepatic portal hypertension predisposes the liver to microcirculatory dysfunction in rats. J Hepatol 2001; 35: 29-36.
11. Vaughan RB, Angus PW, Chin-Dusting JPF. Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation. Gut 2003; 52: 1505-1510.
12. Degertekin B, Ozenirler S, Elbeg S, Akyol G. The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis. Dig Dis Sci 2007; 52: 2622-2628.
13. Abraldes JG, Pasarin M, Rodriguez-Vilarrupla A, Matei V, Gracia-Sancho J, Garcia-Pagan JC, et al. One month cafeteria diet induces NAFLD and liver sinusoidal endothelial dysfunction in rats. J Hepatol 2008; 48: S103, A256.
14. Kunos G, Osei-Hyiaman D. Endocannabinoids and liver disease. Endocannabinoid involvement in obesity and hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1101-1104.
15. Lin HC, Yang YY, Tsai TH, Huang CM, Huang YT, Lee FY, et al. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension J Hepatol 2011; 45: 1145-1153.
16. Adachi T, Bradford BU, Gao W, Bojes HK. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. HEPATOLOGY 1994; 20: 453-460.
17. Lui J, Batkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, et al. Lipopolysacchoride induced anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NFêB independently of platelet-activating factor. J Biol Chem 2003; 278: 45034-45039.
18. Watson AM, Poloyac SM, Howard G, Blouin RA. Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the OB/OB mouse. Drug Metab Dispos 1998; 27: 695-700.
19. LecIercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000; 105: 1067-1075.
20. Bornheim LM, Kim KY, Chen B, Correia MA. Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. Biochem Pharmacol 1995; 50: 677-686
21. Reynaert H, Vaeyens F, Qin H, Hellemans K, Chatterjee N, Winand D, et al. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 2001; 121: 915-930.
22. White CL, Whittington A, Barnes M, Wang Z, Bray GA, Morrison CD. HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin dependent and independent mechanisms. Am J Physiol Endocrinol Metab 2009; 296: E291-299.
23. Haas P, Straub RH, Bedoui S, Nave H. Peripheral but not central leptin treatment increases numbers of circulating NK cells, granulocytes and specific monocyte subpopulations in non-endotoxaemic lean and obese LEW-rats. Regul Peptides 2008; 151: 26-34.
24. Shen J, Sakaida I, Uchida K, Terai S, Okita K. Leptin enhances TNF-α production via p38 and JNK MAPK in LPS-stimulated Kupffer cells. Life Sci 2005; 77: 1502-1515.
25. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 822-825.
26. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. HEPATOLOGY 1994; 20: 453-460.
27. Oinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110: 534-548.
28. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 2002; 90: 711-718.
29. Xiong Y, Tanaka H, Richardson JA, Williams SC, Slaughter CA, Nakamura M, et al. Endothelin-1 stimulates leptin production in adipocytes. J Biol Chem 2001; 276: 28471-28477.
30. Adiarto S, Emoto N, Iwasa N, Yokoyama M. Obesity-induced up-regulation of myocardial endothelin-1 expression is mediated by leptin. Biochem Biophys Res Commun 2007; 353: 623-627.
31. Juan CC, Chuang TY, Lien CC, Lin YJ, Huang SW, Kwok CF, et al. Leptin increases endothelin type A receptor levels in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 2008; 294: E481-487.
32. Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML, et al. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 2003; 278: 28668-28676.